Going beyond HbA1c to understand the benefits of advanced diabetes therapies

Volume: 11, Issue: 1, Pages: 23 - 31
Published: Oct 8, 2018
Abstract
The gold standard for monitoring overall glycemia is HbA1c. However, HbA1c has several important limitations, giving more weight to the prior 2 to 3 months rather than short-term glycemic control. In addition, the level of the HbA1c does not reflect the important interpersonal differences in its relationship with mean glucose, and HbA1c is affected by many common clinical conditions (anemia, uremia) that can interfere with the accuracy of its...
Paper Details
Title
Going beyond HbA1c to understand the benefits of advanced diabetes therapies
Published Date
Oct 8, 2018
Volume
11
Issue
1
Pages
23 - 31
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.